Bosentan 32mg tablets is used for the treatment of pulmonary arterial hypertension. This drug is usable for children aged 3 years and above ...

At this point, we may as well admit it; Samsung is no longer fun. The company has given up being the innovative and ...

SIGN UP TO CONTINUEPrint Subscriber? Sign Up for Full Access!Please sign up for as low as 36 cents per day to continue ...

China’s tablet market experienced a resurgence in 2024, with shipments reaching 29.85 million units, a 4.3% year-on-year ...

ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

The Oppo Pad 3 Pro is a slim, premium tablet. The metal unibody design is well constructed, feeling solid in the hand. It ...

The tablet market has had a tough few years. After booming in 2020 and 2021, sales took a sharp downturn in 2022 and 2023, making tablets the only IT device category that struggled to bounce back. But ...

HONOR has decided to partner with DeepSeek, the most controversial Chinese AI company on the market right now.

Arm-based systems dominated much of the computing industry in 2024. Arm’s Chris Bergey tells Laptop Mag about the advantages ...

Natco Pharma said that it has received final approval of its ANDA for Bosentan tablets for oral suspension (TFOS), which is a generic version of Tracleer by Actelion Pharmaceuticals US Inc.

Natco Pharma announced final approval of its ANDA for Bosentan tablets for oral suspension (TFOS), 32mg, a generic version of Tracleer by Actelion Pharmaceuticals US Inc. NATCO's marketing partner for ...

Taiyo Yuden will benefit from increased passive components per phone as a result of advancing technology in telecommunications. In particular, diffusion of LTE and LTE-advanced networks and phones ...